Announcement

Collapse
No announcement yet.

Netherlands: new method saves lives of 2 H1N1 patients

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Netherlands: new method saves lives of 2 H1N1 patients

    Previous story not from the Netherlands?

    Today an amazing story from the Netherlands about a 54 yo man who was saved from H1N1 flu using a new method.

    He was dying , ventilator could not help him anymore, when the doctors decided to put oxygen straight in his blood.

    Doctors kept doing this for several weeks, in the meantime has badly damaged lungs could recover.

    May I can post the story later, or someone could do this.
    ?Addressing chronic disease is an issue of human rights ? that must be our call to arms"
    Richard Horton, Editor-in-Chief The Lancet

    ~~~~ Twitter:@GertvanderHoek ~~~ GertvanderHoek@gmail.com ~~~

  • #2
    Re: Holland man home for good after H1N1 battle

    Moved original post to US - Ohio.
    Twitter: @RonanKelly13
    The views expressed are mine alone and do not represent the views of my employer or any other person or organization.

    Comment


    • #3
      Re: Netherlands: new method saves lives of 2 H1N1 patients

      AZ Maastricht saves lives flu patients with new treatment

      5.28 A new method has saved the lives of two patients with the H1N1 flu at the Academic Hospital Maastricht (AZM).

      The patients underwent extracorporeal membrane oxygenation ECMO ie through a single catheter in a jugular vein. That means that an artificial lung directly pumps oxygen into the blood so that vital organs are given time to recover.

      The first patient could not be ventilated in a normal way. By ECMO for three weeks to apply, could eventually be cured of a severe lung inflammation.

      Medication and mechanical ventilation in turn made sure that the patient could recover. When illness or injury to heart and / or lungs under control, the organs can take over the work again.

      It may be several months before the patient has completely recovered.

      The treatment according to the azM was successfully appliedtwo times.

      Een niet eerder toegepaste methode heeft het leven gered van twee patiënten met de Mexicaanse griep in het Academisch Ziekenhuis van Maastricht (azM). De patiënten ondergingen een extracorporale membraanoxygenatie oftewel ECMO via een enkele katheter in een halsader. Dat betekent dat er zuurstof via een kunstlong rechtstreeks in het bloed wordt gepompt zodat vitale organen de tijd krijgen om te herstellen.



      Some background on ECMO:

      Extracorporeal membrane oxygenation for severe acute respiratory failure

      Critical Care 2000, 4:156-168doi:10.1186/cc689

      The electronic version of this article is the complete one and can be found online at: http://ccofrum.com/content/4/3/156

      Published: 12 April 2000


      Abstract

      Extracorporeal membrane oxygenation (ECMO) is a technique for providing life support, in case the natural lungs are failing and are not able to maintain a sufficient oxygenation of the body's organ systems.

      ECMO technique was an adaptation of conventional cardiopulmonary bypass technique and introduced into treatment of severe acute respiratory distress syndrome (ARDS) in the 1970s.

      The intial reports of the use of ECMO in ARDS patients were quite enthusiastic, however, in the following years it became clear that ECMO was only of benefit in newborns with acute respiratory failure. In neonates treated with ECMO, survival rates of 80% could be achieved. In adult patients with ARDS, two large randomized controlled trials (RCTs) published in 1979 and 1994 failed to show an advantage of ECMO over convential treatment, survival rates were only 10% and 33%, respectively, in the ECMO groups.

      Since then, ECMO technology as well as conventional treatment of adult ARDS have undergone further improvements. In conventional treatment lung-protective ventilation strategies were introduced and ECMO was made safer by applying heparin-coated equipment, membranes and tubings.

      Many ECMO centres now use these advanced ECMO technology and report survival rates in excess of 50% in uncontrolled data collections. The question, however, of whether the improved ECMO can really challenge the advanced conventional treatment of adult ARDS is unanswered and will need evaluation by a future RCT.

      more:
      ?Addressing chronic disease is an issue of human rights ? that must be our call to arms"
      Richard Horton, Editor-in-Chief The Lancet

      ~~~~ Twitter:@GertvanderHoek ~~~ GertvanderHoek@gmail.com ~~~

      Comment

      Working...
      X